EPCAM and neoplasm: The novel synthesis of doxorubicin hydrochloride (DOX·HCl) and siRNA-loaded polymer vesicles labeled with anti-EpCAM antibody demonstrated effective liver CSC killing and tumor growth inhibition with reduced toxicity to normal cells in vitro [145].